SUBSCRIBE
SUBSCRIBE

New P2Y12 Antagonists Show Mortality Benefit vs. Clopidogrel

August 26, 2010 | 
1 min read
MedPage Today -- Newer P2Y12 inhibitors reduce all-cause mortality compared with clopidogrel (Plavix), the older member of the class, a meta-analysis showed.